Amerise Biosciences Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 0.358 million. Revenue was INR 0.358 million. Net income was INR 0.196 million compared to net loss of INR 0.203 million a year ago.
For the full year, sales was INR 0.359 million compared to INR 0.087 million a year ago. Revenue was INR 0.359 million compared to INR 0.087 million a year ago. Net loss was INR 1.46 million compared to INR 1.19 million a year ago. Basic loss per share from continuing operations was INR 0.02 compared to INR 0.02 a year ago. Diluted loss per share from continuing operations was INR 0.02 compared to INR 0.02 a year ago.